20/20 Biolabs, Inc. Common Stock (NASDAQ: AIDX) last traded at $0.554, up 7.82% on the session. The quote above updates while this page is open; the figures below are drawn from 20/20 Biolabs, Inc. Common Stock’s own filings and are restated only when a new one is published.
20/20 Biolabs, Inc. Common Stock trades on NASDAQ under the ticker AIDX. Its market capitalisation is $7.08 million.
Valuation measures for 20/20 Biolabs, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $7.08M |
|---|---|
| Enterprise value | $5.50M |
| Price / sales | 3.46 |
| Price / book | 4.37 |
| Beta | 0.30 |
Trailing-twelve-month figures tagged in 20/20 Biolabs, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $2.05M |
|---|---|
| Net income (TTM) | -$3.74M |
| Gross margin | 29.56% |
| Operating margin | -162.87% |
| Return on equity | -230.69% |
| Cash | $4.55M |
Range and volume for AIDX over the past 52 weeks.
| 52-week high | $50.00 |
|---|---|
| 52-week low | $0.400 |
| Volume | 230.2K |
| Average volume | 794.4K |
| Previous close | $0.514 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.